sever
acut
respiratori
syndrom
sar
caus
infect
previous
undescrib
coronaviru
cov
lsign
encod
also
known
sarscov
bind
receptor
polymorph
extracellular
neck
region
encod
tandem
repeat
domain
exon
genet
risk
associ
studi
show
individu
homozyg
tandem
repeat
less
suscept
sar
infect
lsign
express
nonsar
sarscovinfect
lung
compar
cell
heterozyg
lsign
cell
homozyg
lsign
show
higher
bind
capac
sarscov
higher
proteasomedepend
viral
degrad
lower
capac
tran
infect
thu
homozygos
lsign
play
protect
role
sar
infect
sar
acut
respiratori
diseas
result
infect
previous
undescrib
coronaviru
sarscov
spread
mainli
respiratori
rout
spike
protein
coronavirus
larg
type
membran
glycoprotein
associ
cellular
receptor
mediat
infect
target
cell
angiotensin
convert
known
function
receptor
sarscov
infect
sequenc
analysi
shown
sarscov
spike
protein
multipl
nlink
glycosyl
site
share
great
similar
sequenc
motif
hiv
envelop
protein
suggest
similar
bind
pattern
two
virus
lsign
liverlymph
nodespecif
grab
nonintegrin
encod
also
known
dcsignr
dcsign
relat
dcsign
dendrit
cellspecif
grab
nonintegrin
encod
homologu
share
amino
acid
ident
unlik
dcsign
express
exampl
dendrit
cell
lsign
express
liver
lymph
node
placenta
extracellular
region
contain
tandem
repeat
highli
conserv
acid
sequenc
follow
ctermin
ctype
carbohydr
recognit
domain
crd
contrast
consider
polymorph
tandem
repeat
domain
exon
consist
three
nine
repeat
pair
segment
seven
repeat
predomin
gener
popul
tandem
repeat
segment
encod
extracellular
neck
region
suggest
import
homooligomer
lsign
cell
surfac
bring
crd
proxim
highaffin
ligand
bind
suggest
heterozyg
express
polymorph
variant
lsign
neck
length
differ
may
prevent
format
heterooligom
may
thu
lead
reduc
ligandbind
affin
lsign
dcsign
share
abil
bind
highmannos
oligosaccharid
crd
lsign
serv
receptor
mani
virus
hiv
hepat
c
ebola
well
mycobacterium
tuberculosi
recent
shown
pseudotyp
lentivir
particl
present
sarscov
spike
protein
bind
dcsign
lsign
recent
data
demonstr
lsign
bind
sarscov
also
shown
individu
suscept
sar
infect
may
depend
genet
factor
host
exampl
hla
class
polymorph
lsign
bind
sarscov
homoor
heterozygos
may
determin
ligandbind
capac
hypothes
homoor
heterozygos
might
affect
individu
suscept
sar
infect
therefor
perform
genet
risk
associ
studi
seri
vitro
experi
examin
biolog
role
lsign
sar
infect
genotyp
confirm
sar
patient
infect
outbreak
well
three
group
control
includ
random
control
consist
healthi
blood
donor
randomli
recruit
outbreak
ii
outpati
control
consist
individu
randomli
recruit
gener
outpati
clinic
least
month
sar
outbreak
clinic
histori
sign
symptom
inflamm
infect
iii
health
care
worker
control
consist
health
care
worker
work
sar
ward
remain
diseasefre
confirm
seroneg
sar
comparison
correspond
control
least
onefifth
sar
patient
hong
kong
elsewher
health
care
worker
also
reflect
seri
subclassifi
sar
patient
two
group
health
care
worker
hereaft
call
health
care
worker
sar
infect
hospit
cours
duti
ii
remain
recruit
commun
commun
sar
tabl
tandem
repeat
exon
genotyp
pcr
follow
gel
electrophoresi
result
verifi
dna
blot
analysi
select
case
repres
genotyp
data
shown
group
except
health
care
worker
control
hardyweinberg
equilibrium
hwe
tabl
high
frequenc
homozyg
genotyp
observ
health
care
worker
control
may
thu
contribut
hardyweinberg
disequilibrium
dna
blot
analysi
repeat
confirm
sampl
genotyp
detect
pcr
five
group
data
shown
statist
signific
differ
genotyp
frequenc
p
clump
method
lsign
homoor
heterozygos
p
w
test
outpati
control
random
control
tabl
sar
patient
health
care
worker
sar
commun
sar
compar
random
control
homozyg
individu
significantli
lower
risk
associ
sar
infect
odd
ratio
confid
interv
ci
tabl
heterozygot
refer
group
analyz
whether
statu
health
care
worker
may
impact
suscept
perform
similar
analysi
separ
nonhealth
care
worker
popul
health
care
worker
popul
nonhealth
care
worker
popul
commun
sar
versu
outpati
control
gave
odd
ratio
ci
p
tabl
health
care
worker
popul
health
care
worker
sar
versu
health
care
worker
control
demonstr
odd
ratio
homozygot
ci
p
tabl
stratifi
analysi
two
popul
test
heterogen
compar
reduc
odd
ratio
nonhealth
care
worker
health
care
worker
popul
odd
ratio
respect
demonstr
signific
differ
p
tabl
subsequ
allow
us
perform
test
overal
associ
base
nonhealth
care
worker
health
care
worker
popul
sar
patient
control
subject
result
demonstr
overal
odd
ratio
ci
p
tabl
confirm
reduc
risk
associ
homozygot
irrespect
whether
individu
health
care
worker
furthermor
outpati
control
random
control
differ
individu
genotyp
frequenc
homoor
heterozygot
frequenc
p
respect
tabl
two
control
group
togeth
combin
control
analysi
sar
patient
versu
combin
control
gave
odd
ratio
homozygot
ci
p
hand
analysi
allel
genotyp
frequenc
show
effect
differ
allel
genotyp
frequenc
either
absent
inconsist
tabl
indic
homoor
heterozygos
per
se
specif
allel
genotyp
constitut
homoor
heterozygos
influenc
suscept
sar
infect
perform
situ
hybrid
lsign
paraffinembed
lung
tissu
lsignspecif
antisens
rna
crna
probe
differenti
express
dcsign
lsign
transfect
cell
line
data
shown
perform
fluoresc
situ
hybrid
fish
time
detect
lsign
cell
alveolar
surfac
fig
nonlesion
sampl
eight
patient
receiv
lung
resect
lung
cancer
sar
infect
also
detect
lsign
cell
seem
scatter
within
alveolar
space
fig
sens
control
lsign
situ
hybrid
neg
fig
furthermor
fish
studi
show
also
express
cell
alveolar
surfac
scatter
within
alveolar
space
nonlesion
lung
sampl
four
eight
lung
cancer
patient
fig
compar
lsign
express
lsign
bright
cell
either
dimor
bright
fig
bright
repres
strong
signal
intens
indic
posit
result
dim
dim
repres
weak
signal
signal
indic
neg
result
sens
control
fish
gave
neg
result
fig
detect
signal
nonlesion
lung
tissu
four
lung
cancer
patient
examin
phenotyp
cell
infect
sarscov
patient
fatal
infect
sar
first
stain
dewax
paraffin
section
monoclon
antibodi
sarscov
nucleocapsid
antigen
fig
perform
fish
situ
hybrid
lsign
fig
section
lung
sampl
identifi
sarscov
antigen
cell
coexpress
lsign
fig
detect
viral
antigen
lsign
bright
dimcel
fig
also
identifi
sarscov
antigen
lsign
dimcel
fig
small
bowel
differ
allel
frequenc
sar
patient
control
subject
either
margin
signific
p
nonhcw
popul
signific
p
hcw
popul
similarli
differ
genotyp
frequenc
either
signific
p
nonhcw
popul
margin
signific
p
hcw
popul
comparison
sar
case
random
control
signific
either
allel
genotyp
frequenc
lsign
mediat
proteasomedepend
viral
degrad
cho
cell
express
data
shown
transient
transfect
lsign
contain
seven
tandem
repeat
lsigncho
n
denot
neck
five
repeat
seven
five
repeat
cotransfect
exon
transfect
express
high
level
lsign
posttransfect
day
flow
cytometri
analysi
confirm
level
surfac
express
compar
heterozyg
homozyg
form
data
shown
transfect
cell
puls
plaqu
form
unit
pfu
sarscov
per
cell
h
extens
wash
cell
lyse
rna
obtain
analysi
copi
number
sequenc
describ
genom
rna
sarscov
part
encod
viral
polymeras
cultur
three
transfect
higher
viral
genom
copi
number
mock
transfect
furthermor
homozyg
lsigncho
cell
higher
bind
capac
heterozyg
transfect
fig
bind
sarscov
transfect
confirm
lsigndepend
copi
number
substanti
reduc
block
monoclon
antibodi
lsign
includ
viral
puls
incub
fig
separ
experi
transfect
puls
viru
h
wash
incub
h
h
total
copi
number
determin
combin
cell
lysat
supernat
bind
lsign
total
viral
copi
number
decreas
substanti
h
h
three
transfect
fig
obviou
cytopath
effect
data
shown
thu
evid
product
viral
replic
furthermor
reduct
total
viral
copi
number
least
h
greater
lsigncho
transfect
fig
addit
viral
copi
number
supernat
h
h
extrem
low
supplementari
fig
onlin
obtain
similar
result
experi
repeat
use
lsigntransfect
cell
type
ii
pneumocyt
cell
line
express
lsign
supplementari
fig
onlin
result
suggest
bind
lsign
littl
viral
dissoci
sarscov
actual
degrad
time
investig
mechan
viral
degrad
lsign
cho
cell
puls
sarscov
incub
presenc
mm
proteasom
inhibitor
proteasom
inhibitor
h
total
viral
copi
number
well
treat
proteasom
inhibitor
significantli
higher
treat
solvent
control
fig
treatment
proteasom
inhibitor
h
lead
excess
cell
death
substanti
extens
wash
cell
subsequ
cultur
h
h
fresh
vero
cell
express
data
shown
use
vitro
propag
sarscov
laboratori
quantif
viral
genom
transcript
show
higher
final
copi
number
note
cultur
cell
homozyg
cell
puls
either
pfucel
pfucel
fig
although
differ
observ
h
supplementari
fig
onlin
moreov
initi
viral
puls
pfucel
incub
h
total
viral
copi
number
significantli
increas
cultur
fresh
vero
cell
viruspuls
lsigncho
cell
viruspuls
mock
transfect
cho
fig
result
impli
lsign
deliv
sarscov
permiss
cell
tran
h
exposur
sarscov
homozyg
lsigncho
cell
lower
abil
tran
infect
heterozyg
transfect
lsign
cell
contain
sarscov
antigen
identifi
sar
lung
small
bowel
sampl
fig
c
possibl
lsign
may
also
abl
facilit
ci
infect
sarscov
examin
possibl
vero
cell
transfect
lsign
infect
pfucel
sar
cov
least
cell
express
surfac
lsign
day
posttransfect
determin
flow
cytometri
data
shown
h
wash
cell
incub
h
h
subsequ
measur
total
nucleocapsid
copi
number
express
lsign
transfect
vero
cell
lsignvero
result
higher
viral
fig
left
nucleocapsid
fig
right
copi
number
infect
vero
cell
pfucel
induc
substanti
cell
death
h
h
cultur
owe
cytopath
effect
viru
data
shown
preclud
studi
use
higher
titer
major
nucleocapsid
gene
sequenc
deriv
subgenom
mrna
produc
upon
activ
replic
result
indic
viru
replic
effici
cell
obtain
similar
result
addit
experi
use
cho
cell
line
transfect
alon
lsign
supplementari
fig
onlin
next
examin
distribut
viral
copi
number
cell
lysat
compar
cultur
supernat
sarscovinfect
lsigntransfect
vero
cell
cell
infect
pfucel
sarscov
incub
h
viral
copi
number
significantli
higher
cell
lysat
lsignvero
cultur
lsigntransfect
mocktransfect
vero
cultur
fig
furthermor
viral
copi
number
significantli
lower
supernat
lsignvero
cultur
lsign
vero
cultur
mocktransfect
vero
cultur
fig
infect
fresh
vero
cell
h
serial
titrat
supernat
harvest
h
cultur
infect
lsignvero
cell
inde
result
substanti
lower
final
viral
genom
copi
number
infect
supernat
infect
lsignvero
cell
mock
transfect
supplementari
fig
onlin
exclud
possibl
express
lsign
permiss
cell
might
interfer
viru
bud
releas
lsignvero
cultur
treat
antibodi
lsign
viral
puls
subsequ
h
incub
notabl
blockad
surfac
lsign
result
increas
number
viral
genom
copi
supernat
reciproc
decreas
cell
lysat
fig
separ
experi
also
treat
lsignvero
cell
mm
egta
addit
h
end
h
cultur
harvest
treatment
egta
calciumchel
reagent
inhibit
revers
calciumdepend
bind
lsign
result
decreas
viral
copi
cellular
lysat
lsignvero
cell
reciproc
increas
supernat
fig
determin
collect
role
lsign
stabl
transfect
lsigntransfect
cho
cell
select
limit
dilut
assay
confirm
express
high
level
lsign
supplementari
fig
onlin
vero
cell
cell
cultur
lsigncho
cell
respect
subsequ
puls
pfu
sarscov
per
vero
cell
vero
cell
also
cultur
number
parent
cho
cell
control
conduct
wash
experi
order
maintain
constant
viral
titer
infect
close
system
differ
total
number
viral
copi
cellular
lysat
supernat
h
cultur
data
shown
signific
reduct
viral
genom
copi
number
h
vero
lsigncho
cultur
vero
cho
cultur
fig
total
number
nucleocapsid
transcript
also
significantli
lower
cultur
homozyg
lsign
transfect
cultur
heterozyg
fig
addit
stabl
clone
lsigncho
also
obtain
prolong
cultur
stabl
clone
subsequ
lost
five
tandem
repeat
lsigncho
cell
cultur
vero
cell
subsequ
expos
pfucel
sarscov
close
infect
system
total
copi
number
lower
cultur
parent
cho
cell
supplementari
fig
among
five
cohort
genotyp
demonstr
hardyweinberg
equilibrium
hwe
except
health
care
worker
control
tabl
sar
case
hong
kong
health
care
worker
like
unaffect
health
care
worker
recruit
studi
may
repres
preselect
group
overrepresent
homozygot
genotyp
nevertheless
direct
comparison
sarsinfect
individu
correspond
control
togeth
stratifi
analysi
show
homozygot
significantli
less
suscept
sar
infect
irrespect
whether
individu
health
care
worker
tabl
reduc
risk
associ
lsign
homozygos
per
se
rather
specif
allel
genotyp
report
primari
organ
sarscov
infect
lung
viru
also
detect
small
bowel
patient
fatal
infect
sarscov
use
situ
hybrid
immunohistolog
shown
presenc
lsign
cell
nonlesion
lung
sampl
lung
cancer
patient
sar
infect
lsign
cell
either
bright
dim
fig
impli
lsign
may
express
least
two
differ
subset
cell
inde
separ
studi
found
lsign
bright
dimcel
express
cytokeratin
indic
epitheli
cell
also
suggest
recent
report
contrast
lsign
bright
bright
cell
express
cytokeratin
data
shown
natur
cell
unknown
need
character
although
lsign
bright
dimcel
consist
found
lung
tissu
nonsar
sampl
lsign
bright
bright
cell
found
sampl
half
nonsar
individu
four
eight
need
investig
nevertheless
find
lsign
consist
express
cell
express
sarscov
antigen
lung
small
bowel
patient
fatal
infect
sar
fig
c
strongli
suggest
lsign
may
involv
sarscov
infect
notabl
sar
antigen
found
lsign
dimcel
sarsinfect
lung
fig
natur
viruscontain
cell
express
known
function
receptor
unclear
alveolar
macrophag
express
supplementari
fig
onlin
macrophagespecif
marker
observ
homozyg
lsign
cell
higher
sarscov
bind
capac
heterozyg
cell
fig
agre
suggest
heterozyg
express
polymorph
variant
lsign
may
result
reduc
ligandbind
affin
bind
lsign
littl
viral
dissoci
virus
undergo
degrad
time
homozyg
cell
effici
heterozyg
cell
fig
report
level
sarscov
subgenom
rna
increas
h
infect
lsignexpress
cell
howev
increas
transient
sarscov
antigen
detect
immunofluoresc
stain
fewer
infect
lsignexpress
cell
argu
effici
product
viral
replic
mediat
lsign
furthermor
lsignmedi
viral
degrad
least
part
proteasomedepend
inhibit
partial
proteasom
inhibitor
fig
although
interfer
proteasom
may
also
lead
indirect
inhibit
upstream
process
involv
degrad
endocytos
sarscov
particl
lsign
also
bind
hiv
siv
mediat
infect
permiss
cell
tran
express
lsign
permiss
cell
facilit
tran
ci
infect
sarscov
least
cell
initi
infect
pfucel
fig
titer
may
repres
set
primari
infect
higher
one
observ
lsigncho
cell
bind
sarscov
effici
mediat
poorer
tran
infect
cell
interest
like
higher
bind
capac
may
lead
effici
intern
degrad
therebi
result
lower
abil
tran
deliveri
viru
separ
experi
viral
copi
number
determin
b
separ
cell
lysat
supernat
cell
lysat
sarsinfect
homozyg
lsignvero
cell
contain
significantli
higher
viral
copi
number
heterozyg
lsign
vero
cell
fig
find
consist
recent
report
infect
sarscov
spike
proteincontain
pseudotyp
viru
incub
luciferas
activ
cell
lysat
correl
viral
copi
number
higher
nonpermiss
cell
transfect
lsign
cell
transfect
alon
reciproc
supernat
sarsinfect
homozyg
lsignvero
cell
significantli
lower
viral
copi
number
supernat
heterozyg
lsignvero
cell
fig
impli
cell
express
lsign
heterozyg
seem
retain
high
proport
virus
cellassoci
form
lead
decreas
level
infecti
virion
supernat
taken
togeth
suggest
lsign
express
permiss
cell
lsign
bright
bright
cell
fig
may
actual
captur
sequest
sar
virus
liber
replic
least
h
incub
viral
copi
number
significantli
increas
captur
absorpt
degrad
releas
virus
via
bind
lsign
would
result
lower
amount
infecti
virion
local
environ
could
limit
subsequ
viral
spread
permiss
cell
infect
vivo
howev
outcom
sarscov
infect
like
combin
lsignmedi
captur
intern
degrad
andor
tran
deliveri
viru
permiss
cell
close
infect
system
wash
procedur
conduct
order
maintain
constant
titer
infect
demonstr
cultur
permiss
cell
homozyg
heterozyg
lsignexpress
cell
significantli
lower
final
viral
genom
subgenom
copi
number
fig
observ
confirm
homozyg
lsign
protect
role
sarscov
infect
summari
shown
genet
riskassoci
studi
homozygot
significantli
lower
risk
sarscov
infect
observ
support
vitro
studi
show
homozyg
lsign
play
protect
role
reduc
final
total
viral
titer
cultur
permiss
cell
part
attribut
increas
bind
capac
homozyg
lsign
result
greater
cell
associ
virion
increas
proteasomedepend
viral
degrad
consequ
lower
capac
tran
infect
result
show
novel
role
lsign
sar
infect
whether
find
also
relev
pathogenesi
diseas
suscept
lsignbind
pathogen
deserv
investig
recruit
subject
casecontrol
genet
associ
studi
sign
inform
consent
prior
approv
relev
institut
review
board
obtain
subject
donat
blood
sar
patient
recruit
four
major
hospit
treat
sar
patient
hong
kong
outbreak
name
queen
mari
hospit
pamela
youd
nethersol
hospit
princess
margaret
hospit
unit
christian
hospit
sar
patient
select
studi
unrel
confirm
serolog
andor
quantit
rtpcr
assay
health
care
worker
remain
commun
control
includ
random
control
consist
healthi
blood
donor
randomli
recruit
outbreak
hong
kong
red
cross
blood
transfus
servic
ii
patient
unaffect
sar
attend
gener
outpati
clinic
recruit
least
two
month
outbreak
iii
health
care
worker
work
sar
ward
remain
diseasefre
confirm
seroneg
sar
serolog
sar
perform
previous
describ
genom
dna
extract
whole
blood
tandem
repeat
exon
sequenc
gene
highli
similar
special
care
taken
design
primer
specif
amplifi
exon
supplementari
tabl
onlin
pcr
perform
use
high
fidel
platinum
taq
dna
polymeras
invitrogen
facilit
amplif
long
short
allel
similar
effici
ml
pcr
consist
pcr
buffer
mm
mgcl
mm
dntp
nm
primer
unit
u
high
fidel
platinum
taq
dna
polymeras
ng
genom
dna
reaction
carri
min
cycl
final
extens
min
amplifi
product
separ
agaros
gel
electrophoresi
wide
lane
width
well
mm
wide
load
ml
pcr
product
provid
good
visual
allel
genotyp
case
check
blind
three
separ
individu
repres
case
confirm
dna
blot
analysi
well
direct
sequenc
genotyp
also
perform
unrel
european
individu
ceph
refer
famili
statist
analysi
genet
associ
heterozygot
homozygot
genotyp
comparison
assess
twotail
w
test
use
spss
softwar
version
odd
ratio
ci
use
measur
strength
associ
genet
risk
associ
studi
mantelhaenzel
test
stratifi
analysi
also
carri
use
spss
comparison
allel
frequenc
genotyp
frequenc
done
use
clump
program
hardyweinberg
exact
test
calcul
markov
chain
method
take
p
cutoff
assess
signific
markov
chain
paramet
dememor
number
number
batch
number
iter
per
batch
vitro
studi
statist
signific
calcul
use
student
twotail
ttest
prepar
antisarscov
nucleocapsid
antibodi
balbc
mice
immun
intraperiton
ml
heatkil
sar
coronaviru
ml
inject
similar
dose
repeat
weekli
month
four
day
final
booster
spleen
cell
immun
mous
fuse
nsi
myeloma
cell
polyethylen
glycol
peg
mw
bdh
pool
fuse
agent
hybridoma
screen
product
antibodi
sar
coronaviru
elisa
produc
specif
antibodi
clone
twice
limit
dilut
purifi
hybridoma
inject
intraperiton
miner
oilprim
mice
product
ascit
fluid
monoclon
antibodi
enrich
ascit
fluid
precipit
ammonium
sulfat
antibodi
react
specif
nucleocapsid
protein
protein
blot
data
shown
immunohistochemistri
sar
nucleocapsid
antigen
situ
hybrid
lsign
fish
immunohistochemistri
perform
mm
paraffin
section
formalinfix
sampl
lung
tissu
eight
adult
lung
resect
lobectomi
lung
cancer
part
nonlesion
lung
tissu
excis
approv
institut
review
board
univers
hong
kong
section
lung
small
bowel
tissu
taken
autopsi
five
patient
fatal
infect
sar
also
retriev
studi
sampl
first
deparaffin
rehydr
microwav
heat
mous
antibodi
sarscov
nucleocapsid
appli
primari
antibodi
overnight
section
incub
antimous
univers
immunoalkalinephosphatas
polym
nichirei
corpor
readytous
h
room
temperatur
color
subsequ
develop
fast
red
substrat
system
sigma
fish
situ
hybrid
perform
describ
previous
section
use
mix
fitclabel
crna
probe
correspond
full
length
cdna
digoxigeninlabel
lsign
crna
probe
correspond
nucleotid
section
mount
medium
fluoresc
dapi
vector
laboratori
electron
imag
immunohistochem
stain
fish
fluoresc
visual
fluoresc
microscop
nikon
eclips
save
pc
section
incub
sheep
antidigoxigenin
alkalin
phosphatas
fab
fragment
roch
h
room
temperatur
final
color
lsign
situ
hybrid
develop
nbt
bcip
substrat
system
roch
section
mount
aqueou
mount
medium
dakocytom
field
immunohistochemistri
fish
fluoresc
imag
subsequ
select
visual
microscop
also
save
electron
imag
comparison
analysi
coloc
antisens
sens
fitclabel
crna
probe
digoxigeninlabel
lsignspecif
crna
probe
gener
nonradioact
rna
label
kit
respect
roch
accord
manufactur
instruct
lsign
express
vector
construct
entir
exon
fragment
b
harbor
five
tandem
repeat
amplifi
genom
dna
allel
carrier
use
supplementari
tabl
end
exon
partial
exon
fragment
end
partial
exon
stop
codon
exon
fragment
c
gene
transcript
amplifi
obtain
aid
research
refer
reagent
program
us
nation
institut
health
nih
use
two
primer
set
stopr
supplementari
tabl
fragment
b
overlap
bp
sequenc
end
exon
mix
extend
first
ten
thermal
cycl
reaction
use
expand
high
fidel
plu
pcr
system
roch
diagnost
without
primer
initi
extens
ad
reaction
gener
complet
fragment
length
exon
exon
addit
thermal
cycl
amplifi
product
fragment
ab
gel
purifi
fragment
ab
c
contain
bp
overlap
sequenc
end
exon
mix
similar
procedur
perform
use
gener
full
length
lsign
subsequ
clone
pgemt
easi
vector
promega
plasmid
extract
subject
dna
sequenc
ensur
error
introduc
lsign
sequenc
lsign
pgemt
subclon
bamhiand
notidigest
vector
invitrogen
sequenc
read
frame
lsign
vector
subsequ
confirm
dna
sequenc
plasmid
cell
line
plasmid
express
lsign
seven
tandem
repeat
exon
obtain
aid
research
program
nih
lsign
clone
describ
cho
vero
cell
maintain
dmem
supplement
fb
unit
ml
penicillin
mg
ml
streptomycin
unless
otherwis
state
lsign
plasmid
lsign
plasmid
mixtur
plasmid
ratio
transfect
cho
cell
vero
cell
use
lipofectamin
invitrogen
accord
manufactur
instruct
lsign
express
verifi
immunostain
lsign
specif
antibodi
clone
aid
research
program
nih
h
transfect
cell
use
immedi
experi
stabl
clone
cho
cell
express
lsign
variant
obtain
limit
dilut
lsigntransfect
cho
cell
select
mg
ml
andor
mg
ml
hygromycin
b
week
homozygos
heterozygos
lsign
stabl
clone
verifi
rtpcr
amplifi
neck
domain
lsign
stabl
clone
maintain
complet
media
contain
select
antibiot
rtpcr
quantif
nucleocapsid
copi
number
total
rna
cultur
cell
extract
use
rneasi
rna
mini
kit
qiagen
viral
rna
cultur
supernat
extract
separ
use
qiamp
viral
rna
kit
qiagen
rna
resuspend
ml
rnasefre
water
total
viral
rna
copi
number
determin
quantit
rtpcr
amplifi
sarscov
sequenc
previous
describ
pcr
sarscov
nucleocapsid
n
sequenc
done
use
nmol
l
forward
revers
primer
supplementari
tabl
follow
condit
min
follow
cycl
reaction
perform
use
abi
prism
sequenc
detector
appli
biosystem
fluoresc
signal
analyz
use
sd
softwar
appli
biosystem
total
copi
number
calcul
standard
known
amount
plasmid
contain
correspond
gene
bind
assay
sarscov
lsign
transfect
treatment
proteasom
inhibitor
lsign
transfect
mock
transfect
cho
cell
puls
pfucel
sarscov
serumfre
dmem
posttransfect
day
h
incub
cell
wash
remov
unbound
virus
immedi
lyse
obtain
rna
analysi
time
point
h
cell
incub
triplic
per
well
plate
complet
media
h
h
determin
viral
nucleocapsid
sequenc
describ
individu
experi
experi
use
proteasom
inhibitor
lsigncho
mocktransfect
cho
cell
puls
pfucel
sarscov
serumfre
dmem
h
posttransfect
day
wash
cell
harvest
time
point
h
remaind
cell
seed
cell
per
well
plate
triplic
cultur
complet
dmem
media
presenc
mm
describ
proteasom
inhibitor
calbiochem
h
accord
manufactur
instruct
dmso
use
vehicl
control
tran
infect
sarscov
lsigntransfect
cho
cell
lsign
transfect
cho
mocktransfect
cho
cell
plate
per
well
plate
posttransfect
day
puls
pfucel
cov
serumfre
dmem
h
wash
vero
cell
ad
well
cultur
h
h
total
rna
extract
well
copi
number
determin
ci
infect
sarscov
lsign
transfect
vero
cell
vero
cell
transfect
lsign
similarli
transfect
cho
cell
describ
posttransfect
day
cell
expos
pfucel
h
wash
cell
incub
cell
per
well
plate
triplic
determin
nucleocapsid
sequenc
h
h
perform
cellular
lysat
supernat
indic
individu
experi
experi
egta
sigma
pb
control
egta
ad
well
final
concentr
mm
end
h
cultur
cell
incub
h
supernat
cellular
rna
harvest
separ
viral
rna
copi
number
determin
block
experi
use
antibodi
lsign
lsign
transfect
cho
cell
plate
plate
incub
serumfre
dmem
contain
either
cocktail
antibodi
lsign
mixtur
clone
mgml
mous
isotyp
control
antibodi
mgml
room
temperatur
min
subsequ
pfucel
sarscov
ad
cultur
cell
incub
h
continu
presenc
antibodi
cell
extens
wash
collect
quantif
transcript
separ
experi
lsigntransfect
vero
cell
plate
plate
incub
serumfre
dmem
contain
either
cocktail
antibodi
lsign
cocktail
mous
isotyp
control
antibodi
mgml
describ
pfucel
sarscov
ad
cultur
cell
incub
h
continu
presenc
antibodi
cell
extens
wash
incub
complet
dmem
media
h
h
replenish
antilsign
antibodi
isotyp
control
antibodi
determin
sequenc
h
h
perform
cellular
lysat
supernat
indic
individu
experi
infect
cultur
vero
stabl
lsigncho
transfect
without
wash
close
system
vero
cell
first
homogen
mix
stabl
transfect
lsigncho
parent
cho
cell
ml
serumfre
dmem
subsequ
infect
sarscov
pfu
per
vero
cell
suspens
h
without
wash
viru
ml
infect
cell
suspens
contain
suspens
vero
cell
lsigncho
ratio
suspens
vero
cell
lsigncho
ratio
place
plate
triplic
addit
ml
complet
media
well
make
